Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a single IV dose of N6022 will have a
significant bronchoprotective effect, compared with placebo, during methacholine challenge.